This inventor holds 1 USPTO granted patent. Top assignee: Monash University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Matthew Watt
Introduction
Matthew Watt is an accomplished inventor based in Clayton, Australia. He has made significant contributions to the field of metabolic disease treatment. His innovative approaches focus on addressing critical health issues such as obesity, insulin resistance, and type 2 diabetes.
Latest Patents
Matthew Watt holds a patent for "Methods and compounds for treatment of metabolic disease." This invention provides methods for treating metabolic diseases using inhibitors of COX-2 or VEGFR and lipid prodrugs of COX-2 inhibitors. In particular, his work emphasizes the use of celecoxib lipid prodrugs that promote the transport of pharmaceutical agents to the lymphatic system, enhancing the release of the parent agent. He has 1 patent to his name.
Career Highlights
Matthew Watt is affiliated with Monash University, where he conducts research and develops innovative solutions for metabolic diseases. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from these conditions.
Collaborations
Matthew collaborates with fellow researcher Natalie Trevaskis, contributing to advancements in their shared field of study.
Conclusion
Matthew Watt's contributions to the treatment of metabolic diseases highlight his innovative spirit and dedication to improving health outcomes. His work continues to pave the way for future advancements in medical treatments.